Clinical Trial Update: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. [Phase 4]

View source ↗

Summary

Phase 4 trial investigating efficacy and safety of paricalcitol to reduce secondary hyperparathyroidism after kidney transplantation; study completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism Due to Renal Causes

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Fundación Senefro | Conditions: Secondary Hyperparathyroidism Due to Renal Causes | Phase 4 | Status: COMPLETED | Results posted: 2018-11-19